Stellate Ganglion Blockade for the Treatment of Refractory Ventricular Arrhythmias is a research paper published in JACC. Clinical electrophysiology (2020). On theSindex it has a DataRank of 0.683. It has been cited 94 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.683
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 16MCPRP30700010
National Institutes of Health
Grant: 5T32HL007101
National Institutes of Health
Grant: GM08600
American Heart Association
Grant: 17MCPRP33460225
Allergan
Grant: unidentified
unidentified
Boston Scientific Corporation
Johnson and Johnson
LivaNova
Medtronic
Allergan
Merit Medical Systems
Bayer Fund
School of Medicine, Indiana University
Biosense Webster
National Heart, Lung, and Blood Institute
Philips
Biotronik
Abbott Laboratories
FWCI
9.44
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals